Nautilus Biotechnology Statistics
Total Valuation
NAUT has a market cap or net worth of $89.94 million. The enterprise value is -$9.47 million.
Important Dates
The next confirmed earnings date is Tuesday, April 29, 2025, before market open.
| Earnings Date | Apr 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NAUT has 126.15 million shares outstanding. The number of shares has increased by 0.41% in one year.
| Current Share Class | 126.15M |
| Shares Outstanding | 126.15M |
| Shares Change (YoY) | +0.41% |
| Shares Change (QoQ) | +0.27% |
| Owned by Insiders (%) | 32.22% |
| Owned by Institutions (%) | 19.99% |
| Float | 46.63M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.43 |
| P/TBV Ratio | 0.43 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 17.40, with a Debt / Equity ratio of 0.15.
| Current Ratio | 17.40 |
| Quick Ratio | 17.02 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -29.86% and return on invested capital (ROIC) is -18.89%.
| Return on Equity (ROE) | -29.86% |
| Return on Assets (ROA) | -18.57% |
| Return on Invested Capital (ROIC) | -18.89% |
| Return on Capital Employed (ROCE) | -34.65% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$456,645 |
| Employee Count | 155 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -71.37% in the last 52 weeks. The beta is 1.21, so NAUT's price volatility has been higher than the market average.
| Beta (5Y) | 1.21 |
| 52-Week Price Change | -71.37% |
| 50-Day Moving Average | 1.07 |
| 200-Day Moving Average | 2.05 |
| Relative Strength Index (RSI) | 38.17 |
| Average Volume (20 Days) | 166,865 |
Short Selling Information
The latest short interest is 424,523, so 0.34% of the outstanding shares have been sold short.
| Short Interest | 424,523 |
| Short Previous Month | 352,327 |
| Short % of Shares Out | 0.34% |
| Short % of Float | 0.91% |
| Short Ratio (days to cover) | 2.75 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -81.48M |
| Pretax Income | -69.64M |
| Net Income | -70.78M |
| EBITDA | -79.50M |
| EBIT | -81.48M |
| Earnings Per Share (EPS) | -$0.56 |
Full Income StatementBalance Sheet
The company has $129.89 million in cash and $30.48 million in debt, giving a net cash position of $99.42 million or $0.79 per share.
| Cash & Cash Equivalents | 129.89M |
| Total Debt | 30.48M |
| Net Cash | 99.42M |
| Net Cash Per Share | $0.79 |
| Equity (Book Value) | 208.73M |
| Book Value Per Share | 1.66 |
| Working Capital | 125.19M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$59.15 million and capital expenditures -$2.88 million, giving a free cash flow of -$62.03 million.
| Operating Cash Flow | -59.15M |
| Capital Expenditures | -2.88M |
| Free Cash Flow | -62.03M |
| FCF Per Share | -$0.49 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |